Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Infections | AIDS | Reproductive Medicine | Research | News

Back to Health News

New Vaccine Strategy May Fight Genital Herpes, Mouse Study Suggests

Last Updated: October 17, 2012.

 

Approach may also protect against other sexually transmitted infections, researchers say

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Approach may also protect against other sexually transmitted infections, researchers say.

WEDNESDAY, Oct. 17 (HealthDay News) -- A new vaccination approach may provide protection against genital herpes as well as other sexually transmitted infections, including HIV, according to a new study involving mice.

The vaccination model developed by researchers at Yale University focuses on tissue in the vagina where viral exposure occurs, rather than the immune system's antibodies, known as T-cells, which circulate throughout the body.

In conducting the study, the researchers recruited T cells to vaginal tissue using what they called a "prime and pull" strategy. They first primed the mice's immune systems by triggering a system-wide T-cell response. Then, they recruited activated T cells to vaginal tissue by topically applying chemokines, substances that help mobilize immune cells.

The researchers said the strategy could offer protection against genital herpes, caused by the herpes simplex virus, by limiting it's spread into the sensory neurons. They noted this vaccination model may also protect against other sexually transmitted infections, such as HIV-1.

"This new vaccine approach can work with any vaccines that elicit strong T-cell immunity, and will set the stage for protection against infectious diseases by setting up memory T-cells at the site of exposure," study lead author Akiko Iwasaki, professor of immunobiology at Yale School of Medicine and a member of Yale Cancer Center's molecular virology program, explained in a university news release.

"This technology can be potentially applied to other infectious agents that enter through a given portal, such as the genital tract, respiratory tract, the skin, or gut," Iwasaki added.

The researchers noted that genital herpes is the most commonly sexually transmitted infection. Currently, there is no cure for the condition.

The study was published online Oct. 17 in Nature.

Experts note that results from animal research, while sometimes promising, are not always replicated in humans.

More information

The U.S. Centers for Disease Control and Prevention provides more information on genital herpes.

SOURCE: Yale University, news release, Oct. 17, 2012

Copyright © 2012 HealthDay. All rights reserved.


Previous: Is Your Brain Working as You Nap? Next: Painkiller Abuse by Kids Way Up, Study Finds

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.